Health
The US FDA has accepted AstraZeneca’s standalone flu vaccine for review
AstraZeneca said the U.S. Food and Drug Administration has accepted the company’s application for approval for patients or caregivers to administer its nasal influenza vaccine.
The US FDA has accepted AstraZeneca’s standalone flu vaccine for review
AstraZeneca said Tuesday that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s application for approval for patients or caregivers to
EU establishes new mechanisms to prevent shortages of medicines
The European Commission on Tuesday launched a series of short-term measures to prevent shortages of medicines this winter and next as a temporary solution while
Suspected counterfeit Ozempic forces hospitalisation of several people in Austria
Several people were hospitalised in Austria after consuming suspected counterfeit versions of the diabetes drug Ozempic, the country’s health safety agency said. The patients suffered
Pfizer will set the price for COVID-19 treatment with Paxlovid at $1390 per course
Pfizer on Wednesday said it would set the U.S. price for its COVID-19 antiviral drug Paxlovid at nearly $1400 for a five-day course when the
Nestle begins work on ‘companion products’ for weight loss medication
Nestle on Thursday said it has started work on products that will “complement” weight-loss drugs such as Novo Nordisk’s revolutionary Wegovy, hoping to capitalise on
European regulator warns EU and UK over counterfeit Ozempic pens
The European medicines regulator on Wednesday warned of pre-filled pens falsely labelled as Novo Nordisk’s popular diabetes drug Ozempic at wholesalers in the European Union
Merck’s Keytruda has received FDA approval to expand its use in lung cancer
The US Food and Drug Administration has approved the expanded use of Merck & Co’s blockbuster immunotherapy Keytruda in early-stage patients with non-small cell lung
Hyloris Pharma has received US FDA approval for its pain treatment
US health regulators have approved Hyloris Pharmaceuticals’ drug for post-operative pain, the Belgian company said on Wednesday, adding that it expects to launch the non-opioid
EU regulator supports use of Merck’s drug to treat viral infections
Merck & Co said the European Union’s medicines regulator has recommended a registration authorisation for the company’s Prevymis drug to treat a type of infection